Arctoris Acquires Eli Lilly’s ‘Life Science Studio’ Drug Discovery Automation Lab
Through the strategic acquisition of Eli Lilly’s San Diego ‘Life Science Studio’, Arctoris’ has doubled the size of its existing
Read moreThrough the strategic acquisition of Eli Lilly’s San Diego ‘Life Science Studio’, Arctoris’ has doubled the size of its existing
Read moreGoogle DeepMind has introduced AlphaProteo, an advanced AI system designed to generate novel proteins that bind to specific molecular targets.
Read moreimusyn’s Dyemer & myDyemer are a pioneering class of ready-to-use and loadable T Cell staining reagents, developed for precise quantification
Read moreResearchers have devised a novel human 3D model for Alzheimer’s Disease, enabling the study of immune cell involvement in the
Read moreThe Hamburg headquartered publicly listed drug discovery and development company Evotec and Variant Bio, a US-based biotech company leveraging the
Read morePreclinical data shows that Nutcracker’s mRNA drug candidate NTX-470 effectively targets CD3 T cells, demonstrating selective engagement with minimal unintended
Read moreMMI has introduced the next generation of laser microdissection systems – the CellCut. Breakthrough Advancements for Clean and Precise Dissection This
Read moreThe use of Fluorescence Cross-Correlation Spectroscopy (FCCS) in Drug Discovery and Development An Intana Bioscience .pdf Case Study/Presentation The .pdf
Read moreReadyCell has developed an advanced range of ready-to-use HEK293 Cell-based In Vitro Plates for studying uptake drug-transporter interactions in preclinical
Read moreReadyCell has developed an advanced range of MDCKII Cell-based Plates for In Vitro Drug-transporter Studies in preclinical testing and drug
Read more